Animal studies have indicated a decrease in the expression of Sfrp5 in obese models, while Sfrp5 deficiency causes insulin resistance, glucose intolerance, and hepatosteatosis [8,13]. This evidence concerns the gene SFRP5 and Glucose intolerance.